178 related articles for article (PubMed ID: 38547061)
1. The β2-adrenergic receptor associates with CXCR4 multimers in human cancer cells.
Liang J; Seghiri M; Singh PK; Seo HG; Lee JY; Jo Y; Song YB; Park C; Zalicki P; Jeong JY; Huh WK; Caculitan NG; Smith AW
Proc Natl Acad Sci U S A; 2024 Apr; 121(14):e2304897121. PubMed ID: 38547061
[TBL] [Abstract][Full Text] [Related]
2. Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α
Gao X; Enten GA; DeSantis AJ; Volkman BF; Gaponenko V; Majetschak M
Biochem Biophys Res Commun; 2020 Jul; 528(2):368-375. PubMed ID: 32085899
[TBL] [Abstract][Full Text] [Related]
3. Resolving Membrane Protein-Protein Interactions in Live Cells with Pulsed Interleaved Excitation Fluorescence Cross-Correlation Spectroscopy.
Christie S; Shi X; Smith AW
Acc Chem Res; 2020 Apr; 53(4):792-799. PubMed ID: 32227891
[TBL] [Abstract][Full Text] [Related]
4. The chemokine CXC4 and CC2 receptors form homo- and heterooligomers that can engage their signaling G-protein effectors and βarrestin.
Armando S; Quoyer J; Lukashova V; Maiga A; Percherancier Y; Heveker N; Pin JP; Prézeau L; Bouvier M
FASEB J; 2014 Oct; 28(10):4509-23. PubMed ID: 25053617
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning.
Nijmeijer S; Leurs R; Smit MJ; Vischer HF
J Biol Chem; 2010 Sep; 285(38):29632-41. PubMed ID: 20622011
[TBL] [Abstract][Full Text] [Related]
6. Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization.
Ménard L; Ferguson SS; Zhang J; Lin FT; Lefkowitz RJ; Caron MG; Barak LS
Mol Pharmacol; 1997 May; 51(5):800-8. PubMed ID: 9145918
[TBL] [Abstract][Full Text] [Related]
7. β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4.
LaRocca TJ; Schwarzkopf M; Altman P; Zhang S; Gupta A; Gomes I; Alvin Z; Champion HC; Haddad G; Hajjar RJ; Devi LA; Schecter AD; Tarzami ST
J Cardiovasc Pharmacol; 2010 Nov; 56(5):548-59. PubMed ID: 20729750
[TBL] [Abstract][Full Text] [Related]
8. Stoichiometric analysis of oligomeric states of three class-A GPCRs, chemokine-CXCR4, dopamine-D2, and prostaglandin-EP1 receptors, on living cells.
Kawano K; Yagi T; Fukada N; Yano Y; Matsuzaki K
J Pept Sci; 2017 Jul; 23(7-8):650-658. PubMed ID: 28626925
[TBL] [Abstract][Full Text] [Related]
9. Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations.
Civciristov S; Ellisdon AM; Suderman R; Pon CK; Evans BA; Kleifeld O; Charlton SJ; Hlavacek WS; Canals M; Halls ML
Sci Signal; 2018 Oct; 11(551):. PubMed ID: 30301787
[TBL] [Abstract][Full Text] [Related]
10. Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes.
Watts AO; van Lipzig MM; Jaeger WC; Seeber RM; van Zwam M; Vinet J; van der Lee MM; Siderius M; Zaman GJ; Boddeke HW; Smit MJ; Pfleger KD; Leurs R; Vischer HF
Br J Pharmacol; 2013 Apr; 168(7):1662-74. PubMed ID: 23170857
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type 1A receptor regulates β-arrestin binding of the β
Tóth AD; Gyombolai P; Szalai B; Várnai P; Turu G; Hunyady L
Mol Cell Endocrinol; 2017 Feb; 442():113-124. PubMed ID: 27908837
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine attenuates CXCR4 expression and the corresponding invasion of MDA-MB-231 breast cancer cells via β2-adrenergic receptors.
Wang LP; Jin J; Lv FF; Cao J; Zhang J; Wang BY; Shao ZM; Hu XC; Wang ZH
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1170-81. PubMed ID: 25912576
[TBL] [Abstract][Full Text] [Related]
13. α
Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
[TBL] [Abstract][Full Text] [Related]
14. Consequences of ChemR23 heteromerization with the chemokine receptors CXCR4 and CCR7.
de Poorter C; Baertsoen K; Lannoy V; Parmentier M; Springael JY
PLoS One; 2013; 8(2):e58075. PubMed ID: 23469143
[TBL] [Abstract][Full Text] [Related]
15. Homo- and hetero-oligomerization of β2-adrenergic receptor in receptor trafficking, signaling pathways and receptor pharmacology.
Wnorowski A; Jozwiak K
Cell Signal; 2014 Oct; 26(10):2259-65. PubMed ID: 25049076
[TBL] [Abstract][Full Text] [Related]
16. Internal trafficking and surface mobility of a functionally intact beta2-adrenergic receptor-green fluorescent protein conjugate.
Barak LS; Ferguson SS; Zhang J; Martenson C; Meyer T; Caron MG
Mol Pharmacol; 1997 Feb; 51(2):177-84. PubMed ID: 9203621
[TBL] [Abstract][Full Text] [Related]
17. Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells.
Brancaccio D; Diana D; Di Maro S; Di Leva FS; Tomassi S; Fattorusso R; Russo L; Scala S; Trotta AM; Portella L; Novellino E; Marinelli L; Carotenuto A
J Med Chem; 2018 Apr; 61(7):2910-2923. PubMed ID: 29522685
[TBL] [Abstract][Full Text] [Related]
18. CHIP-MYTH: a novel interactive proteomics method for the assessment of agonist-dependent interactions of the human β₂-adrenergic receptor.
Kittanakom S; Barrios-Rodiles M; Petschnigg J; Arnoldo A; Wong V; Kotlyar M; Heisler LE; Jurisica I; Wrana JL; Nislow C; Stagljar I
Biochem Biophys Res Commun; 2014 Mar; 445(4):746-56. PubMed ID: 24561123
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 Antagonists: A Screening Strategy for Identification of Functionally Selective Ligands.
Castaldo C; Benicchi T; Otrocka M; Mori E; Pilli E; Ferruzzi P; Valensin S; Diamanti D; Fecke W; Varrone M; Porcari V
J Biomol Screen; 2014 Jul; 19(6):859-69. PubMed ID: 24632660
[TBL] [Abstract][Full Text] [Related]
20. Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.
Heuninck J; Perpiñá Viciano C; Işbilir A; Caspar B; Capoferri D; Briddon SJ; Durroux T; Hill SJ; Lohse MJ; Milligan G; Pin JP; Hoffmann C
Mol Pharmacol; 2019 Dec; 96(6):778-793. PubMed ID: 31092552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
